(Q36319540)

13 August 2017

1 reference

title

Review article: alternative approaches to the long-term management of GERD. (English)

1 reference

13 August 2017

1 reference

Fennerty MB

1

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Alimentary Pharmacology & Therapeutics

13 August 2017

published in

1 reference

13 August 2017

volume

22 Suppl 3

1 reference

13 August 2017

page(s)

39-44

1 reference

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

Step-down management of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

PPI use in the OTC era: who to treat, with what, and for how long?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

Enteryx implantation for GERD: expanded multicenter trial results and interim postapproval follow-up to 24 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

Nonresorbable copolymer implantation for gastroesophageal reflux disease: a randomized sham-controlled multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

Endoscopic full-thickness plication for the treatment of GERD: a multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02711.X

Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003245.PUB2

10.1111/J.1365-2036.2005.02711.X

12 January 2024

Identifiers

DOI

1 reference

13 August 2017

1 reference